Mette Julsgaard (Mette Julsgaard Nielsen)

Forsker, 1. reservelæge

Profile photo

Mette Julsgaard

Forsker, 1. reservelæge

  • Institut for Klinisk Medicin - Lever-, Mave- og Tarmsygdomme
  • Institut for Klinisk Medicin - Medicinsk afdeling, Horsens
Postaddresse:
Palle Juul-Jensens Boulevard 35
8200
Aarhus N
Danmark
Postaddresse:
Sundvej 30
8700
Horsens
Danmark

E-mail: mjn@clin.au.dk

Publikationer

Surgery Due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an Ecco Confer Multicentre Case Series (Scar Study)

Chaparro, M., Kunovský, L., Aguas, M., Livne, M., Rivière, P., Shitrit, A. B-G., Myrelid, P., Arroyo, M., Barreiro-de Acosta, M., Bautista, M., Biancone, L., Avni Biron, I., Boysen, T., Carpio, D., Castro, B., Dragoni, G., Ellul, P., Holubar, S. D., de Jorge, M. Á., Leo, E., Manceñido, N., Moens, A., Molnár, T., Ramírez de la Piscina, P., Ricanek, P., Sebkova, L., Sempere, L., Teich, N., Gisbert, J. P., Julsgaard, M. & ECCO CONFER taskforce, sep. 2022, I: Journal of Crohn's & colitis. 16, 9, s. 1428-1435 8 s.

European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

Torres, J., Chaparro, M., Julsgaard, M., Katsanos, K., Zelinkova, Z., Agrawal, M., Ardizzone, S., Campmans-Kuijpers, M., Dragoni, G., Ferrante, M., Fiorino, G., Flanagan, E., Frias Gomes, C., Hart, A., Hedin, C. R., Juillerat, P., Mulders, A., Myrelid, P., O'Toole, A., Rivière, P., Scharl, M., Selinger, C. P., Sonnenberg, E., Toruner, M., Wieringa, J. & Van der Woude, C. J., 25 aug. 2022, (E-pub ahead of print) I: Journal of Crohn's & colitis.

Anti-TNFα Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series

MacIsaac, M. B., Julsgaard, M., Flanagan, E., Rowe, S., Ross, A. L., Gearry, R. B., Gibson, P. R. & Bell, S. J., apr. 2022, I: Inflammatory Bowel Diseases. 28, 4, s. 652–655 4 s.

Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy

Grosen, A., Bellaguarda, E., Liljeqvist-Soltic, I., Mejlby Hansen, M., Skytte, A-B., Julsgaard, M., Hanauer, S. B. & Kelsen, J., 25 feb. 2022, (E-pub ahead of print) I: Inflammatory Bowel Diseases.

Editorial: safety of ustekinumab in pregnancy-are we there yet?

Skejø, C., Vestergaard, T. & Julsgaard, M., feb. 2022, I: Alimentary Pharmacology and Therapeutics. 55, 4, s. 495-496 2 s.

Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study

Julsgaard, M., Baumgart, D. C., Baunwall, S. M. D., Hansen, M. M., Grosen, A., Bibby, B. M., Uldbjerg, N., Kjeldsen, J., Sørensen, H. G., Larsen, L., Wildt, S., Weimers, P., Haderslev, K. V., Vind, I., Svenningsen, L., Brynskov, J., Lyhne, S., Vestergaard, T., Hvas, C. L., Kelsen, J. & NOVA Study Group, nov. 2021, I: Alimentary Pharmacology and Therapeutics. 54, 10, s. 1320-1329 10 s.

Positive Predictive Value of Diagnostic Codes for Inflammatory Bowel Disease in the Danish National Patient Registry Among Individuals 50+Years, Using Patient Records as Reference Standard

Rye, C., Rubin, K. H., Moller, F. T., Julsgaard, M., Jess, T. & Andersen, V., maj 2021, I: Clinical epidemiology. 13, s. 335-344 10 s.

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes

Julsgaard, M., Hvas, C. L., Gearry, R. B., Gibson, P. R., Fallingborg, J., Sparrow, M. P., Bibby, B. M., Connell, W. R., Brown, S. J., Kamm, M. A., Lawrance, I. C., Vestergaard, T., Svenningsen, L., Baekdal, M., Kammerlander, H., Walsh, A., Boysen, T., Bampton, P., Radford-Smith, G., Kjeldsen, J., Andrews, J. M., Subramaniam, K., Moore, G. T., Jensen, N. M., Connor, S. J., Wildt, S., Wilson, B., Ellard, K., Christensen, L. A. & Bell, S. J., jan. 2020, I: Inflammatory Bowel Diseases. 26, 1, s. 93-102 10 s.

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

Moens, A., van der Woude, C. J., Julsgaard, M., Humblet, E., Sheridan, J., Baumgart, D. C., Gilletta De Saint-Joseph, C., Nancey, S., Rahier, J-F., Bossuyt, P., Cremer, A., Dewit, S., Eriksson, C., Hoentjen, F., Krause, T., Louis, E., Macken, E., Milenkovic, Z., Nijs, J., Posen, A., Van Hootegem, A., Van Moerkercke, W., Vermeire, S., Bar-Gil Shitrit, A. & Ferrante, M., jan. 2020, I: Alimentary Pharmacology and Therapeutics. 51, 1, s. 129-138 10 s.

Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease

Grosen, A., Bungum, M., Hvas, C. L., Julsgaard, M., Cordelli, E. & Kelsen, J., 1 jun. 2019, I: Gastroenterology. 156, 8, s. 2342-2344 3 s.

Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors

Grosen, A., Bungum, M., Christensen, L. A., Cordelli, E., Larsen, O. H., Leter, G., Julsgaard, M., Vestergaard, T., Villani, P., Hvas, C. L. & Kelsen, J., maj 2019, I: Journal of Crohn's & colitis. 13, 5, s. 564-571 8 s.

Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men with Inflammatory Bowel Disease

Grosen, A., Nersting, J., Bungum, M., Christensen, L. A., Schmiegelow, K., Spanò, M., Julsgaard, M., Cordelli, E., Leter, G., Larsen, P. B., Hvas, C. L. & Kelsen, J., 1 jan. 2019, I: Journal of Crohn's & colitis. 13, 1, s. 3-11 9 s.

Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease

Bank, S., Julsgaard, M., Abed, O. K., Burisch, J., Broder Brodersen, J., Pedersen, N. K., Gouliaev, A., Ajan, R., Nytoft Rasmussen, D., Honore Grauslund, C., Roug, S., Galsgaard, J., Sprogøe Høyer Finsen, D., Lindby, K., Danish IBD Genetics Working Group, Sørensen, J., Larsen, L., Rohr Andersen, M., Brandslund, I., Thomassen, M., Green, A., Bo Bojesen, A., Bek Sørensen, S., Vogel, U. & Andersen, V., 2019, I: Alimentary Pharmacology and Therapeutics. 49, 7, s. 890-903 14 s.

Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease

de Silva, P. S., O'Toole, A., Marc, L. G., Ulysse, C. A., Testa, M. A., Julsgaard, M., Ngyuen, D., Ananthakrishnan, A., Laursen, T., Højgaard, A., Christensen, L. A., Korzenik, J. & Friedman, S., 12 okt. 2018, I: Inflammatory Bowel Diseases. 24, 11, s. 2350-2359 10 s.

Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study

Lo, B., Julsgaard, M., Vester-Andersen, M. K., Vind, I. & Burisch, J., okt. 2018, I: European Journal of Gastroenterology and Hepatology. 30, 10, s. 1130-1136 7 s.

Vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease

Julsgaard, M., Kjeldsen, J., Brock, B. & Baumgart, D. C., jul. 2018, I: Alimentary Pharmacology and Therapeutics. 48, 3, s. 386-388 3 s.

Biologisk behandling af gravide med kronisk inflammatorisk tarmsygdom

Julsgaard (Mette Julsgaard Nielsen), M., jun. 2018, I: BestPractice - Gastroenterologi. 4, s. 18 22 s.

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M., Verreth, A., Lobaton, T., Gravito-Soares, E., Julsgaard, M., Savarino, E., Magro, F., Avni Biron, I., Lopez-Serrano, P., Casanova, M. J., Gompertz, M., Vitor, S., Arroyo, M., Pugliese, D., Zabana, Y., Vicente, R., Aguas, M., Bar-Gil Shitrit, A., Gutierrez, A., Doherty, G. A., Fernandez-Salazar, L., Martínez Cadilla, J., Huguet, J. M., O'Toole, A., Stasi, E., Manceñido Marcos, N., Villoria, A., Karmiris, K., Rahier, J. F., Rodriguez, C., Diz-Lois Palomares, M., Fiorino, G., Benitez, J. M., Principi, M., Naftali, T., Taxonera, C., Mantzaris, G., Sebkova, L., Iade, B., Lissner, D., Ferrer Bradley, I., Lopez-San Roman, A., Marin-Jimenez, I., Merino, O., Sierra, M., Van Domselaar, M., Caprioli, F., Guerra, I., Peixe, P., Piqueras, M., Rodriguez-Lago, I., Ber, Y., van Hoeve, K., Torres, P., Gravito-Soares, M., Rudbeck-Resdal, D., Bartolo, O., Peixoto, A., Martin, G., Armuzzi, A., Garre, A., Donday, M. G., Martín de Carpi, F. J. & Gisbert, J. P., mar. 2018, I: American Journal of Gastroenterology. 113, s. 396-403 8 s.

Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

Julsgaard, M., Kjeldsen, J., Bibby, B. M., Brock, B. & Baumgart, D. C., feb. 2018, I: Gastroenterology. 154, 3, s. 752-754 3 s.

Pregnancy outcome in four women with inflammatory bowel disease treated with budesonide MMX

Vestergaard, T., Jørgensen, S. M. D., Christensen, L. A. & Julsgaard, M., 2018, I: Scandinavian Journal of Gastroenterology. 53, 12, s. 1459-1462 4 s.

Submandibular Sialoadenitis in an Infant Exposed to Adalimumab and Infliximab in Utero

Vestergaard, T., Brock, B., Christensen, L. A. & Julsgaard, M., okt. 2017, I: Journal of Crohn's & colitis. 11, 10, s. 1284-1285 2 s.

Vedolizumab safety in pregnancy and newborn outcomes

Julsgaard, M., Kjeldsen, J. & Baumgart, D. C., okt. 2017, I: Gut. 66, 10, s. 1866-1867 2 s.

Immunoglobulin and Infliximab Concentrations in Dichorionic Twins Exposed to Infliximab in Utero

Vestergaard, T., Kammerlander, H., Brock, B. & Julsgaard, M., 1 sep. 2017, I: Journal of Crohn's & colitis. 11, 9, s. 1152-1153 2 s.

Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease

Julsgaard, M., Hvas, C. L., Gearry, R. B., Vestergaard, T., Fallingborg, J., Svenningsen, L., Kjeldsen, J., Sparrow, M. P., Wildt, S., Kelsen, J. & Bell, S. J., jul. 2017, I: Inflammatory Bowel Diseases. 23, 7, s. 1240-1246 7 s.

Reply: When Is It Safe to Administer Live Vaccines to Infants Exposed to Anti-Tumor Necrosis Factor Agents In Utero?

Julsgaard, M., Hvas, C. L., Christensen, L. A. & Bell, S. J., 1 nov. 2016, I: Gastroenterology. 151, 6, s. 1250-1251 2 s.

Adherence and quality of care in IBD

Bager, P., Julsgaard, M., Vestergaard, T., Christensen, L. A. & Dahlerup, J. F., nov. 2016, I: Scandinavian Journal of Gastroenterology. 51, 11, s. 1326-31 6 s.

Adherence to medical treatment in relation to pregnancy, birth outcome & breastfeeding behavior among women with Crohn’s disease

Julsgaard, M., 1 jul. 2016, I: Danish Medical Journal. 63, 7, B5263.

Adherence to medical treatment in relation to pregnancy, birth outcome & breastfeeding behavior among women with Crohn's disease

Julsgaard, M., jul. 2016, I: Danish Medical Journal. 63, 7

Adherence to medical treatment in relation to pregnancy, birth outcome and breastfeeding behavior among women with Crohn's disease: PhD dissertation

Julsgaard, M., jul. 2016, 7 udg. Danish Medical Journal. 71 s.

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R. B., Fallingborg, J., Hvas, C. L., Bibby, B. M., Uldbjerg, N., Connell, W. R., Rosella, O., Grosen, A., Brown, S. J., Kjeldsen, J., Wildt, S., Svenningsen, L., Sparrow, M. P., Walsh, A., Connor, S. J., Radford-Smith, G., Lawrance, I. C., Andrews, J. M., Ellard, K. & Bell, S. J., 7 apr. 2016, I: Gastroenterology. s. 110-119 10 s., 151.

Is fecal calprotectin the better tool to monitor disease activity in pregnant IBD patients?

Julsgaard (Mette Julsgaard Nielsen), M., Christensen, L. A., Hvas, C. L., Fallingborg, J., Svenningsen, L., Kjeldsen, J., Sparrow, M. P., Wildt, S. & Bell, S. J., 2016, s. Supplement 1 (A451-A452). 2 s.

Adalimumab and Infliximab Levels in Neonates (ERA Study)

Julsgaard (Mette Julsgaard Nielsen), M., Christensen, L. A., Gibson, P. R., Gearry, R., Fallingborg, J., Kjeldsen, J., Wildt, S., Svenningsen, L., Connell, W., Hvas, C. L., Sparrow, M. P., Walsh, A., Connor, S. J., Radford-Smith, G., Lawrence, I., Andrews, J. M., Ellard, K., Rosella, O., Grosen, A., Santamaria, J. & Bell, S. J., apr. 2015, I: Gastroenterology. 148, Supplement 1, s. S-108

Adherence - Does patient involvement and satisfaction matter?

Bager, P., Julsgaard, M., Vestergaard, T., Christensen, L. A. & Dahlerup, J. F., 20 feb. 2015.

Adalimumab and Infliximab clearance in neonates (ERA study)

Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R., Fallingborg, J., Kjeldsen, J., Wildt, S., Svenningsen, L., Connell, W., Hvas, C. L., Sparrow, M. P., Walsh, A., Connor, S. J., Radford-Smith, G., Lawrence, I., Andrews, J. M., Ellard, K., Rosella, O., Grosen, A., Santamaria, J. & Bell, S., feb. 2015, I: Journal of Crohn's and Colitis.

Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study)

Julsgaard, M., Christensen, L. A., Gibson, P. R., Fallingborg, J., Gearry, R., Kjeldsen, J., Connell, W., Sparrow, M. P., Radford-Smith, G., Andrews, J. M., Connor, S. J., Lawrence, I., Wildt, S., Moore, G. T., Svenningsen, L., Rosella, O., Grosen, A. & Bell, S. J., okt. 2014, I: United European Gastroenterology Journal.

Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn's disease

Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., 4 jun. 2014, I: Scandinavian Journal of Gastroenterology. s. 1-9 9 s.

Biologisk behandling af gravide

Julsgaard, M. & Christensen, L. A., maj 2014, I: BestPractice. Reumatologi. 7, 25, s. 25-29 5 s.

Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease

Grosen, A., Julsgaard, M., Kelsen, J. & Christensen, L. A., 1 feb. 2014, I: Journal of Crohn's & colitis. 8, 2, s. 175 176 s.

Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth

Julsgaard, M., Christensen, L. A., Fallingborg, J., Gearry, R., Radford-Smith, G., Walsh, A., Kjeldsen, J., Sparrow, M. P., Andrews, J. M., Connor, S. J., Lawrence, I., Gibson, P. R., Rosella, O., Grosen, A. & Bell, S. J., feb. 2014, I: Journal of Crohn's and Colitis. 8, DOP041

Pregnancy outcome and counselling of anti-TNF-α treated IBD women.

Julsgaard, M., Christensen, L. A., Lawrence, I., Gearry, R., Connell, W., Grosen, A., Svenningsen, L., Andrews, J. M., Bampton, P., Walsh, A., Moore, G. T., Radford-Smith, G., Hvas, C. L., Kjeldsen, J., Connor, S. J., Sparrow, M. P., Fallingborg, J. & Bell, S. J., feb. 2014, I: Journal of Crohn's and Colitis. 8, P377

Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study)

Julsgaard, M., Christensen, L. A., Gibson, P. R., Fallingborg, J., Gearry, R., Walsh, A., Kjeldsen, J., Connell, W., Sparrow, M. P., Radford-Smith, G., Andrews, J. M., Connor, S. J., Lawrence, I., Wildt, S., Moore, G. T., Svenningsen, L., Rosella, O., Grosen, A. & Bell, S. J., 2014, I: Journal of Gastroenterology and Hepatology. 29, suppl. S2, s. 117 118 s.

Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease

Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., 2014, I: Scandinavian Journal of Gastroenterology. 49, s. 302-308 7 s.

Adalimumab levels in an infant

Julsgaard, M., Brown, S., Gibson, P. & Bell, S., aug. 2013, I: Journal of Crohn's & colitis. 7, 7, s. 597-8 2 s.

Serum sickness-like reaction due to Infliximab reintroduction during pregnancy

Grosen, A., Julsgaard, M. & Christensen, L. A., jun. 2013, I: Journal of Crohn's & colitis. 7, 5, s. e191

Chicken pox infection in a three months old infant exposed in utero to Adalimumab

Johnsson, A., Avlund, S., Grosen, A. & Julsgaard, M., 1 apr. 2013, I: Journal of Crohn's & colitis. 7, 3, s. e116-7

Is medical treatment a risk factor for adverse birth outcomes among women with Crohn’s disease?

Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., feb. 2013, I: Journal of Crohn's & colitis. P207

Intra-uterine exposure to anti-TNF-α therapy (ERA study): Neonatal levels of anti TNF antibodies correlate with duration of therapy in pregnancy

Julsgaard, M., Christensen, L. A., Gearry, R., Andrews, J., Rosella, O., Connor, S., Walsh, A., Brown, S., Connell, W., Gibson, P. R. & Bell, S. J., 2013, I: Journal of Gastroenterology and Hepatology. 28, suppl. 2, s. 85-86 2 s.

A population-based study: Do women with ulcerative colitis breastfeed?

Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., 13 dec. 2012, I: Inflammatory Bowel Diseases. vol.18, no.12, s. 31

Postpartum adherence to medical tratment among women with ulcerative colitis

Julsgaard, M., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., okt. 2012, I: Gut. 61, supplement 3, A287

Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis

Julsgaard, M., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 1 jul. 2011, I: Inflammatory Bowel Diseases. 17, 7, s. 1573-80 8 s.

A populationbased study: Do women with Crohn’s disease breastfeed?

Nielsen, M. J., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2011, I: Journal of Crohn's & colitis. vol.5, Issue 1, P055

Adherence to medical treatment among women with ulcerative colitis

Julsgaard, M., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2010, I: Scandinavian Journal of Gastroenterology. vol.45, supplement 247, s. 59-60

Medical treatment of ulcerative colitis patients prior to and during pregnancy

Nielsen, M. J., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2010, I: Scandinavian Journal of Gastroenterology. vol.45, supplement 247, s. 71-72

Postpartum adherence to medical treatment among women with Crohn’s disease

Nielsen, M. J., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2010, I: Gut. vol.59, Supplement3, s. P0976

Self-reported antenatal adherence to medical treatment among pregnant women with Crohn's disease

Nielsen, M. J., Nørgaard, M., Holland-Fischer, P. & Christensen, L. A., 2010, I: Alimentary Pharmacology and Therapeutics.

Azathioprine treatment during lactation: Authors reply

Christensen, L. A., Dahlerup, J. F., Nielsen, M. J., Fallingborg, J. F. & Schmiegelow, K., jul. 2009, I: Alimentary Pharmacology and Therapeutics. 30, 1, s. 91 1 s.

Azathioprine treatment during lactation

Christensen, L. A., Dahlerup, J. F., Nielsen, M. J., Fallingborg, J. F. & Schmiegelow, K., 2008, I: Alimentary Pharmacology and Therapeutics. 28, 10, s. 1209-13 4 s.

Intestinal obstruction and bacteremia - complications of capsule endoscopy

Dam, G., Nielsen, M. J. & Christensen, L. A., 2008, I: Endoscopy. 40 Suppl 2, s. E155-6

Self reported adherence to medical therapy among IBD patients in relation to pregnancy

Nielsen, M. J. & Christensen, L. A., 2007, I: Gut. vol.56, A157, no.3

Aktiviteter

Congress of the European Crohn's and Colitis Organisation

Mette Julsgaard (Deltager)

14 feb. 201817 feb. 2018

Internationale forskningssamarbejder - erfaringer & tips

Mette Julsgaard (Foredragsholder)

15 jan. 2018

Connecting Mind & Gut

Mette Julsgaard (Deltager)

15 nov. 201717 nov. 2017

IBD-håndbogen, forfatter

Mette Julsgaard (Konsulent)

1 nov. 201731 dec. 2017

BestPractice - Gastroenterologi (Tidsskrift)

Mette Julsgaard (Redaktør)

2017 → …

Italian and European experiences come across: IBD and beyond

Mette Julsgaard (Taler)

24 sep. 2016

UEGW (United European Gastroenterology Week)

Mette Julsgaard (Taler)

27 okt. 2015

DDW (Digestive Disease Week)

Mette Julsgaard (Taler)

18 maj 2015

European Crohn & Colitis Organisation Conference

Mette Julsgaard (Taler)

19 feb. 2015

United European Gastroenterology Week

Mette Julsgaard (Taler)

18 okt. 2014

ECCO 14

Mette Julsgaard (Taler)

21 feb. 2014

ph d day 2014

Mette Julsgaard (Deltager)

24 jan. 2014

Årsmøde i Dansk Selskab for Gastroenterologi og Hepatologi

Mette Julsgaard (Taler)

6 sep. 20137 sep. 2013

Congress of ECCO - Inflammatory Bowel Disease 2013

Mette Julsgaard (Taler)

14 feb. 2013

PhD Day 2013

Mette Julsgaard (Taler)

11 jan. 2013

American Crohn’s & Colitis Foundation’s Research & Clinical Conference

Mette Julsgaard (Taler)

14 dec. 2012

Gastroenterologisk netværksmøde, Region Midt

Mette Julsgaard (Taler)

22 nov. 2012

IBD – seksualitet, fertilitet, amning og medicinsk behandling

Mette Julsgaard (Foredragsholder)

1 nov. 2012

United European Gastroenterology Week (UEGW)

Mette Julsgaard (Taler)

24 okt. 2012

Pædiatrisk Gastroenterologisk årsmøde

Mette Julsgaard (Taler)

24 sep. 2012

Årsmøde i Dansk Selskab for Gastroenterologi og Hepatologi

Mette Julsgaard (Taler)

7 sep. 2012

Current knowledge: IBD, Pregnancy & biological therapy

Mette Julsgaard (Foredragsholder)

4 maj 2012

ERA study: Intra-uterine exposure to anti-TNF-alfa therapy

Mette Julsgaard (Foredragsholder)

4 maj 2012

IBD allstars conference

Mette Julsgaard (Deltager)

2 apr. 2012

Reviewer for tidsskriftet GERM (Tidsskrift)

Mette Julsgaard (Fagfællebedømmer)

2012 → …

Research in Gastroenterology in Denmark

Mette Julsgaard (Foredragsholder)

12 dec. 2011

18th National symposium on Hepatitis B and C

Mette Julsgaard (Deltager)

19 nov. 2011

IBD Clinical Excellence symposium 3

Mette Julsgaard (Deltager)

12 nov. 2011

IBD - fertilitet, graviditet og amning: Netværksmøde for gastroenterologiske sygeplejersker i Jylland og på Fyn

Mette Julsgaard (Foredragsholder)

21 sep. 2011

Årsmøde i Dansk Selskab for Gastroenterologi og Hepatologi

Mette Julsgaard (Taler)

2 sep. 2011

Congress of ECCO - Inflammatory Bowel Disease 2011

Mette Julsgaard (Taler)

24 feb. 2011

PhD Day

Mette Julsgaard (Deltager)

14 jan. 2011

United European Gastroenterology Week (UEGW)

Mette Julsgaard (Taler)

23 okt. 2010

Nordic Pharmacoepidemiological Network conference

Mette Julsgaard (Taler)

okt. 2010

National Pregnancy Registration

Mette Julsgaard (Foredragsholder)

3 sep. 2010

Årsmøde i Dansk Selskab for Gastroenterologi og Hepatologi

Mette Julsgaard (Taler)

3 sep. 2010

Nordic Gastroenterology Congress

Mette Julsgaard (Taler)

8 jun. 2010

Dansk Farmako-Epidemiologisk selskabs årsmøde

Mette Julsgaard (Taler)

15 apr. 2010

Nordic Pharmacoepidemiological Network conference

Mette Julsgaard (Taler)

16 mar. 2010

Congress of ECCO - Inflammatory Bowel Diseases 2010

Mette Julsgaard (Taler)

feb. 2010

PhD Day 2010

Mette Julsgaard (Deltager)

18 jan. 2010

Medlem af bestyrelsen i PhD-foreningen, det Sundhedsvidenskabelige Fakultet, Aarhus Univesitet (Ekstern organisation)

Mette Julsgaard (Medlem)

20102011

Medlem af guideline udvalget under Dansk Selskab for Gastroenterologi og Hepatologi: Medicinsk behandling af kroniske inflammatoriske tarmsygdomme under graviditet og amning. (Ekstern organisation)

Mette Julsgaard (Medlem)

20102011

American Crohn’s & Colitis Foundation’s Research & Clinical Conference

Mette Julsgaard (Deltager)

2 dec. 2009

Nordic Pharmacoepidemiological Network conference

Mette Julsgaard (Deltager)

20 okt. 2009

IBD- fertilitet, graviditet og amning

Mette Julsgaard (Foredragsholder)

8 sep. 2009

• Årsmøde i Dansk Selskab for Gastroenterologi og Hepatologi

Mette Julsgaard (Taler)

4 sep. 2009

Medlem af arbejdsgruppen, ”den nye studieordning - inflammationsblokken” det Sundhedsvidenskabelig Fakultet, Aarhus Universitet (Ekstern organisation)

Mette Julsgaard (Medlem)

20092010

Underviser i Psykiatri

Mette Julsgaard (Deltager)

20092011

IBD – fertilitet, graviditet, ammeperiode & medicinsk behandling

Mette Julsgaard (Foredragsholder)

5 nov. 2008

Dansk kirurgisk 100 års jubilæum

Mette Julsgaard (Taler)

11 jun. 2008

PhD day 2008

Mette Julsgaard (Taler)

18 jan. 2008

IBD – fertilitet, graviditet, ammeperiode & medicinsk behandling

Mette Julsgaard (Foredragsholder)

11 dec. 2007

1) Graviditet og fødsel med Colitis Ulcerosa og Morbus Crohn. 2) Forskning i Colitis Ulcerosa og Morbus Crohn i forbindelse med graviditet

Mette Julsgaard (Foredragsholder)

24 nov. 2007

United European Gastroenterology Week (UEGW)

Mette Julsgaard (Taler)

27 okt. 2007

Næstformand i Studienævnet, det sundhedsvidenskabelige fakultet, Aarhus Universitet (Ekstern organisation)

Mette Julsgaard (Medlem)

20072009

Kompliance hos kvinder med IBD

Mette Julsgaard (Foredragsholder)

24 okt. 2006

• Årsmøde i Dansk Selskab for Gastroenterologi og Hepatologi

Mette Julsgaard (Taler)

1 sep. 2006

Congress of ECCO - Inflammatory Bowel Disease 2006

Mette Julsgaard (Deltager)

1 mar. 2006

Medlem af Medicinerrådet, det sundhedsvidenskabelige fakultet, Aarhus Universitet (Ekstern organisation)

Mette Julsgaard (Medlem)

20052009

Projekter

Obstetrics: Overførsel af jern fra mor til barn

Julsgaard, M., Uldbjerg, N., Hansen, A. S., Vestergaard, T. C. V., Kelsen, J., Baunwall, S. M. D., Grønbæk, H., Dahlerup, J. F., Hvas, C. L., Grosen, A., Nemeth, E. & Sangkhae, V.

03/12/201801/12/2023

The influence of anti-TNF-alpha treatment on placental function and pregnancy outcome in reumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and inflammatory bowel disease.

Vestergaard, T. C. V., Kelsen, J., Helmig, R. B., Julsgaard, M. & Laurberg, T. B.

19/08/201831/08/2021

Validation of the Inflammatory Bowel Disease Disability Index in Denmark

Burisch, J., Lo, B. Z., Julsgaard, M., Vind, I. & Kajbaek, M.

01/01/201701/08/2018

Obstetrics: Behandling med Vedolizumab og Ustekinumab af gravide kvinder med kronisk inflammatorisk tarmsygdom

Julsgaard, M., Kelsen, J., Hvas, C. L., Bibby, B. M., Uldbjerg, N., Larsen, L., Kjeldsen, J., Vind, I., Wildt, S., Munkholm, P., Grosen, A., Baumgart, D. C., Hansen, M. M., Baunwall, S. M. D. & Vestergaard, T. C. V.

01/10/201631/03/2020

Seksuel dysfunktion ved mænd med kronisk inflammatorisk tarmsygdom

Vestergaard, T. C. V., Julsgaard, M., Grosen, A., Kristensen, L. S., Blixt, T., Højgaard, A., Fallingborg, J., Munck, L. K., Hvas, C. L., Kelsen, J. & Christensen, L. A.

01/09/201601/12/2018

Sexual dysfunction in female Inflammatory Bowel Disease patients

Friedman, S., de Silva, P. S., Marc, L. G., Ulysse, C. A., Testa, M. A., Julsgaard, M., Ngyuen, D., Ananthankrishnan, A., Laursen, T., Christensen, L. A., Højgaard, A. & Korzenik, J.

01/06/201531/12/2018

I-CARE, IBD cancer and serious infections in Europe

Peyrin-Biroulet, L., Beaugerie, L., Rahier, J., Baert, F. & Julsgaard, M.

01/02/201501/10/2020

TEDDY: Long-term safety of in utero exposure to anti-TNF-alpha therapy for the treatment of inflammatory bowel disease (European multicenter study)

Gispert, J. P., Sanchez, M. C. & Julsgaard, M.

01/08/201401/08/2018

Prospective observational cohort study of fertility intentions and of outcomes among women exposed to anti-TNF-α therapy for Inflammatory Bowel Disease (IBD).

Julsgaard, M., Christensen, L. A., Fallingborg, J., Kjeldsen, J., Bell, S., Gearry, R., Gibson, P., Andrews, J., Connor, S., Walsh, A., Lawrence, I., Radford-Smith, G., Moore, G. & Bampton, P.

01/02/201231/07/2018

Graviditet, fødselsudkomme og amning: betydning af medicinsk behandling, compliance og rygning blandt kvinder med kronisk inflammatorisk tarmsygdom

Julsgaard, M., Christensen, L. A. & Nørgaard, M.

01/12/200901/04/2014

Self-reported adherence to medical therapy among IBD patients in relation to pregnancy.

Julsgaard, M. & Christensen, L. A.

01/02/200615/06/2007